PlainPharmaWatch

CMS Open Payments · Tool

exocad America, Inc. vs Circa Scientific, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Circa Scientific, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,069, versus 1,781 for the other company. Its single largest recorded recipient represents 0.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

exocad America, Inc.
HHI 1,781 · top recipient 0.2%
Ranked #794 of 1,838 companies by HHI
Circa Scientific, Inc.
HHI 2,069 · top recipient 0.2%
Ranked #740 of 1,838 companies by HHI

Payment Overview

Total Payments
$54.9K
% of Industry
0.0%
Transactions
13
Avg per Transaction
$4.2K
Recipients
13
Avg per Recipient
$4.2K
Payment Types
3
Top Payment Type
Long-Term Medical Supply or Device Loan
Total Payments
$54.8K
% of Industry
0.0%
Transactions
13
Avg per Transaction
$4.2K
Recipients
11
Avg per Recipient
$5.0K
Payment Types
3
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

exocad America, Inc. vs Circa Scientific, Inc. - total reported payments in CMS Open Payments PY2024

exocad America, Inc.$54.9KCirca Scientific, Inc.$54.8K

Payment Types Breakdown

exocad America, Inc.

Long-Term Medical Supply or Device Loan $49.8K

90.8%

Honoraria $4.9K

8.9%

Consulting Fee $179.93

0.3%

Circa Scientific, Inc.

Consulting Fee $11.4K

20.9%

Travel and Lodging $4.6K

8.4%

Food and Beverage $243.30

0.4%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

exocad America, Inc.

  1. 1

    JEFFREY W HOROWITZ

    $10,820.00 · 2 txns

  2. 2

    JEFFREY ZAFFOS

    $10,820.00 · 2 txns

  3. 3

    ISAAC DAVID TAWIL

    $10,820.00 · 2 txns

  4. 4

    DANIEL GARY BUTTERMAN

    $10,820.00 · 2 txns

  5. 5

    MICHAEL DAVID SCHERER

    $6,520.00 · 1 txns

Circa Scientific, Inc.

  1. 1

    Jason Bradfield

    $4,000.00 · 3 txns

  2. 2

    Andrew Locke

    $3,750.00 · 3 txns

  3. 3

    Danesh Modi

    $3,700.00 · 1 txns

  4. 4

    Michael Shane Lloyd

    $2,475.90 · 1 txns

  5. 5

    Jonathan Weiss

    $2,248.22 · 2 txns

Summary Comparison

Metric exocad America, Inc. Circa Scientific, Inc.
Total Payments $54.9K $54.8K
% of Industry Total 0.0% 0.0%
Transaction Count 13 13
Avg per Transaction $4.2K $4.2K
Recipient Count 13 11
Avg per Recipient $4.2K $5.0K
Payment Type Count 3 3
Top Payment Type Long-Term Medical Supply or Device Loan Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.